January 2023 FDA Recall Drug by Preferred Pharmaceuticals, Inc.
D-0173-2023 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Preferred Pharmaceuticals, Inc. on January 16, 2023 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in IN and the recall is currently terminated.

Recall Number: D-0173-2023

Reason for Recall
Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Initiated
01-16-2023
Reported
02-01-2023
Quantity
9 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Preferred Pharmaceuticals, Inc.
Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.

Batch or Lot Expiration Information

Lot# Lot: K3022Q, Expiration date: 3/31/2025